Episode 4: Matt speaks with Philip Ross, one of the most experienced and successful bankers in healthcare, about the M&A landscape and his decision to join Jefferies last year episode artwork

EPISODE · Jun 30, 2025 · 26 MIN

Episode 4: Matt speaks with Philip Ross, one of the most experienced and successful bankers in healthcare, about the M&A landscape and his decision to join Jefferies last year

from Off-Target Effects with Matt Gline · host BiotechTV

Philip Ross talks about the outlook for M&A in our industry, and describes the pharma revenue growth demands that will be driving it. He discusses what qualities make targets attractive, and how the industry has changed over time during the course of his career. Plus, what attracted him to Jefferies.

Episode metadata supplied by the publisher feed · Published Jun 30, 2025

Embed this episode

Ready to play

Episode 4: Matt speaks with Philip Ross, one of the most experienced and successful bankers in healthcare, about the M&A landscape and his decision to join Jefferies last year

0:00 26:46

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Off-Target Effects with Matt Gline?

This episode is 26 minutes long.

When was this Off-Target Effects with Matt Gline episode published?

This episode was published on June 30, 2025.

Can I download this Off-Target Effects with Matt Gline episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!